Attribution of Adverse Events Following Coronary Stent Placement Identified Using Administrative Claims Data.
| Title: | Attribution of Adverse Events Following Coronary Stent Placement Identified Using Administrative Claims Data. |
|---|---|
| Authors: | Dhruva SS; University of California, San Francisco, School of Medicine and San Francisco Veterans Affairs Healthcare System San Francisco CA.; National Clinician Scholars Program Yale School of Medicine New Haven CT.; Center for Outcomes Research and Evaluation Yale-New Haven Hospital New Haven CT.; Parzynski CS; Center for Outcomes Research and Evaluation Yale-New Haven Hospital New Haven CT.; Gamble GM; Center for Outcomes Research and Evaluation Yale-New Haven Hospital New Haven CT.; Curtis JP; Center for Outcomes Research and Evaluation Yale-New Haven Hospital New Haven CT.; Section of Cardiovascular Medicine Department of Medicine, and National Clinician Scholars Program Yale School of Medicine New Haven CT.; Desai NR; Center for Outcomes Research and Evaluation Yale-New Haven Hospital New Haven CT.; Section of Cardiovascular Medicine Department of Medicine, and National Clinician Scholars Program Yale School of Medicine New Haven CT.; Yeh RW; Richard A. and Susan F. Smith Center for Outcomes Research in Cardiology Boston MA.; Division of Cardiovascular Medicine Beth Israel Deaconess Medical Center Boston MA.; Harvard Medical School Boston MA.; Baim Institute for Clinical Research Boston MA.; Masoudi FA; Division of Cardiology Department of Medicine University of Colorado Anschutz Medical Campus Aurora CO.; Kuntz R; Medtronic, Inc. Minneapolis MN.; Shaw RE; Department of Clinical Informatics California Pacific Medical Center San Francisco CA.; Marinac-Dabic D; Office of Clinical Evidence and Analysis Center for Devices and Radiological Health U.S. Food and Drug Administration Silver Spring MD.; Sedrakyan A; Department of Health Policy and Research Weill Cornell Medicine New York Presbyterian Hospital New York NY.; Normand ST; Department of Health Care Policy Harvard Medical School Boston MA.; Department of Biostatistics Harvard T.H. Chan School of Public Health Harvard University Boston MA.; Krumholz HM; National Clinician Scholars Program Yale School of Medicine New Haven CT.; Center for Outcomes Research and Evaluation Yale-New Haven Hospital New Haven CT.; Section of Cardiovascular Medicine Department of Medicine, and National Clinician Scholars Program Yale School of Medicine New Haven CT.; Department of Health Policy and Management Yale School of Public Health New Haven CT.; Ross JS; National Clinician Scholars Program Yale School of Medicine New Haven CT.; Center for Outcomes Research and Evaluation Yale-New Haven Hospital New Haven CT.; Department of Health Policy and Management Yale School of Public Health New Haven CT.; Section of General Medicine Department of Medicine, and National Clinician Scholars Program Yale School of Medicine New Haven CT. |
| Source: | Journal of the American Heart Association [J Am Heart Assoc] 2020 Feb 18; Vol. 9 (4), pp. e013606. Date of Electronic Publication: 2020 Feb 16. |
| Publication Type: | Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, U.S. Gov't, P.H.S. |
| Language: | English |
| Journal Info: | Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 101580524 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2047-9980 (Electronic) Linking ISSN: 20479980 NLM ISO Abbreviation: J Am Heart Assoc Subsets: MEDLINE |
| Imprint Name(s): | Original Publication: Oxford : Wiley-Blackwell |
| MeSH Terms: | Administrative Claims, Healthcare* ; Drug-Eluting Stents* ; Medicare*; Percutaneous Coronary Intervention/*adverse effects ; Percutaneous Coronary Intervention/*instrumentation; Coronary Restenosis/mortality ; Coronary Restenosis/therapy ; Coronary Thrombosis/mortality ; Coronary Thrombosis/therapy ; Myocardial Infarction/mortality ; Myocardial Infarction/therapy ; Percutaneous Coronary Intervention/mortality ; United States/epidemiology ; Aged ; Aged, 80 and over ; Databases, Factual ; Female ; Humans ; Male ; Product Surveillance, Postmarketing ; Registries ; Retreatment ; Risk Assessment ; Risk Factors ; Time Factors ; Treatment Outcome |
| Abstract: | Background More than 600 000 coronary stents are implanted during percutaneous coronary interventions (PCIs) annually in the United States. Because no real-world surveillance system exists to monitor their long-term safety, claims data are often used for this purpose. The extent to which adverse events identified with claims data can be reasonably attributed to a specific medical device is uncertain. Methods and Results We used deterministic matching to link the NCDR (National Cardiovascular Data Registry) CathPCI Registry to Medicare fee-for-service claims for patients aged ≥65 years who underwent PCI with drug-eluting stents (DESs) between July 1, 2009 and December 31, 2013. We identified subsequent PCIs within 1 year of the index procedure in Medicare claims as potential safety events. We linked these subsequent PCIs back to the NCDR CathPCI Registry to ascertain how often the revascularization could be reasonably attributed to the same coronary artery as the index PCI (ie, target vessel revascularization). Of 415 306 DES placements in 368 194 patients, 33 174 repeat PCIs were identified in Medicare claims within 1 year. Of these, 28 632 (86.3%) could be linked back to the NCDR CathPCI Registry; 16 942 (51.1% of repeat PCIs) were target vessel revascularizations. Of these, 8544 (50.4%) were within a previously placed DES: 7652 for in-stent restenosis and 1341 for stent thrombosis. Of 16 176 patients with a claim for acute myocardial infarction in the follow-up period, 4446 (27.5%) were attributed to the same coronary artery in which the DES was implanted during the index PCI (ie, target vessel myocardial infarction). Of 24 288 patients whose death was identified in claims data, 278 (1.1%) were attributed to the same coronary artery in which the DES was implanted during the index PCI. Conclusions Most repeat PCIs following DES stent implantation identified in longitudinal claims data could be linked to real-world registry data, but only half could be reasonably attributed to the same coronary artery as the index procedure. Attribution among those with acute myocardial infarction or who died was even less frequent. Safety signals identified using claims data alone will require more in-depth examination to accurately assess stent safety. |
| References: | J Am Coll Cardiol. 2014 Jun 24;63(24):2659-73. (PMID: 24632282); J Interv Cardiol. 2007 Dec;20(6):425-46. (PMID: 18042048); J Am Coll Cardiol. 1997 Feb;29(2):459-65. (PMID: 9015006); Am Heart J. 2016 Jan;171(1):64-72.e1-2. (PMID: 26699602); Clin Cardiol. 2014 Aug;37(8):505-13. (PMID: 24797884); JACC Cardiovasc Interv. 2010 Oct;3(10):1096-9. (PMID: 20965476); Ann Intern Med. 2018 Aug 7;169(3):183-185. (PMID: 29868760); J Am Heart Assoc. 2020 Feb 18;9(4):e013606. (PMID: 32063087); JAMA Cardiol. 2017 Jul 1;2(7):750-757. (PMID: 28538984); JAMA. 2018 Jul 10;320(2):133-134. (PMID: 29868861); P T. 2018 Aug;43(8):464-472. (PMID: 30100687); J Am Coll Cardiol. 2001 Jun 15;37(8):2240-5. (PMID: 11419906); JAMA Cardiol. 2017 Jul 1;2(7):758. (PMID: 28538976); N Engl J Med. 2016 Dec 8;375(23):2293-2297. (PMID: 27959688); Am Heart J. 2004 Jul;148(1):99-104. (PMID: 15215798); N Engl J Med. 2007 Mar 8;356(10):981-4. (PMID: 17296826); JAMA. 2017 Jul 25;318(4):332-334. (PMID: 28742887); Circulation. 2007 May 1;115(17):2344-51. (PMID: 17470709); Eur Heart J. 2007 Jul;28(14):1709-16. (PMID: 17556348); Fed Regist. 2013 Sep 24;78(185):58785-828. (PMID: 24066364); J Am Coll Cardiol. 2017 Mar 21;69(11):1427-1450. (PMID: 28025065); Ann Intern Med. 2017 Nov 7;167(9):675-676. (PMID: 29049832); Nat Rev Cardiol. 2016 Jun;13(6):350-9. (PMID: 27009423); JAMA. 2016 Sep 20;316(11):1153-4. (PMID: 27398696); J Am Coll Cardiol. 2012 Oct 16;60(16):1484-8. (PMID: 22999725); JAMA. 2015 Aug 11;314(6):604-12. (PMID: 26262798); Circ Cardiovasc Interv. 2019 May;12(5):e007451. (PMID: 31084236); J Am Coll Cardiol. 2016 Oct 25;68(17):1898-1907. (PMID: 27765193) |
| Grant Information: | U01 FD004585 United States FD FDA HHS; R01 HS022882 United States HS AHRQ HHS; U01 FD005938 United States FD FDA HHS; R01 HL136708 United States HL NHLBI NIH HHS |
| Contributed Indexing: | Keywords: drug‐eluting stent; percutaneous coronary intervention; real‐world data; registry; surveillance |
| Entry Date(s): | Date Created: 20200218 Date Completed: 20201214 Latest Revision: 20240727 |
| Update Code: | 20260130 |
| PubMed Central ID: | PMC7070203 |
| DOI: | 10.1161/JAHA.119.013606 |
| PMID: | 32063087 |
| Database: | MEDLINE |
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, U.S. Gov't, P.H.S.